6-136822571-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000541292.6(PEX7):c.-95T>C variant causes a 5 prime UTR, NMD transcript change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.553 in 1,144,364 control chromosomes in the GnomAD database, including 178,215 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.51 ( 19992 hom., cov: 35)
Exomes 𝑓: 0.56 ( 158223 hom. )
Consequence
PEX7
ENST00000541292.6 5_prime_UTR, NMD_transcript
ENST00000541292.6 5_prime_UTR, NMD_transcript
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.497
Genes affected
PEX7 (HGNC:8860): (peroxisomal biogenesis factor 7) This gene encodes the cytosolic receptor for the set of peroxisomal matrix enzymes targeted to the organelle by the peroxisome targeting signal 2 (PTS2). Defects in this gene cause peroxisome biogenesis disorders (PBDs), which are characterized by multiple defects in peroxisome function. There are at least 14 complementation groups for PBDs, with more than one phenotype being observed in cases falling into particular complementation groups. Although the clinical features of PBD patients vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins into the organelle. Defects in this gene have been associated with PBD complementation group 11 (PBD-CG11) disorders, rhizomelic chondrodysplasia punctata type 1 (RCDP1), and Refsum disease (RD). [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.569 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PEX7 | NM_000288.4 | upstream_gene_variant | ENST00000318471.5 | NP_000279.1 | ||||
PEX7 | XM_006715502.3 | upstream_gene_variant | XP_006715565.1 | |||||
PEX7 | XM_047418874.1 | upstream_gene_variant | XP_047274830.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PEX7 | ENST00000541292.6 | c.-95T>C | 5_prime_UTR_variant, NMD_transcript_variant | 1/11 | 5 | ENSP00000441004 | ||||
PEX7 | ENST00000318471.5 | upstream_gene_variant | 1 | NM_000288.4 | ENSP00000315680 | P1 | ||||
PEX7 | ENST00000367756.8 | upstream_gene_variant | 3 | ENSP00000356730 |
Frequencies
GnomAD3 genomes AF: 0.506 AC: 76951AN: 152078Hom.: 19989 Cov.: 35
GnomAD3 genomes
AF:
AC:
76951
AN:
152078
Hom.:
Cov.:
35
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.561 AC: 556246AN: 992168Hom.: 158223 Cov.: 13 AF XY: 0.560 AC XY: 282554AN XY: 504782
GnomAD4 exome
AF:
AC:
556246
AN:
992168
Hom.:
Cov.:
13
AF XY:
AC XY:
282554
AN XY:
504782
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.506 AC: 76974AN: 152196Hom.: 19992 Cov.: 35 AF XY: 0.504 AC XY: 37529AN XY: 74422
GnomAD4 genome
AF:
AC:
76974
AN:
152196
Hom.:
Cov.:
35
AF XY:
AC XY:
37529
AN XY:
74422
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Rhizomelic chondrodysplasia punctata type 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 10, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 14, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Peroxisome biogenesis disorder 9B Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 10, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at